Related to this topic: Leaflets | Support | Patient+ | UK Guidelines | Online Videos | News | Weblinks | Poem/Story | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Drug Abuse - Unusual Presentations

Managing drug abusers in primary care involves not only treating patients who admit to their dependency but also recognising the signals in those who are reluctant to share this information. Not infrequently, you will also be approached by temporary patients attempting to obtain drugs by deception. GPs need to be alert to the following clues:

  • Temporary residents just passing through the area
  • Patients with an overly familiar knowledge of the pharmacopoeia demanding analgesia for renal colic, sickle-cell crises, etc.
  • Patient gives evasive answers
  • Signs of heavy smoking, strange smoke smells (cannabis, cocaine, heroin)
  • Acetone or glue smell on breath (solvent abuse)
  • Small pupils (opiates)
  • Needle tracks on arms, groin, legs, between toes; intravenous access difficult
  • Abscesses and lymphadenopathy in nodes draining injection sites
  • Signs of drug associated illnesses (e.g. endocarditis. AIDS, chronic viral hepatitis)
Common presentations of drug abusers in general practice

Patients may present with a variety of medical conditions but the GP may not be aware of the history of drug dependency. The following are a list of common scenarios:

  • Patient found unconscious - consider narcotics, barbiturates, solvents, and benzodiazepine (see also Opiate Poisoning and Coma)
  • Psychosis - consider Ecstasy, LSD, amphetamine, anabolic steroids1
  • Agitation - common with benzodiazepines
  • Asthma/dyspnoea - consider opiate-induced pulmonary oedema, asthma (may follow the smoking of heroin)2,3
  • Lung abscess -may be a complication of right-sided Staphylococcal endocarditis - common in intravenous drug abusers4
  • Fever/PUO/shivering - may be only sign of endocarditis4
  • Shivering and headache - due to chemical/organism contamination of intravenous drug, if suspicious outline risks, offer immediate referral to secondary care - may need blood cultures, antibiotics, e.g. gentamicin.
  • Hyperpyrexia - consider Ecstasy, be wary of associated myoglobinuria, DIC, renal failure
  • Abscesses - if over injection site, then often of mixed organisms
  • DVT - may result from injecting suspension of tablets into groin, consider acute compartment syndrome, organise a CK test5
  • Pneumonia - Pneumococcus, haemophilus, tuberculosis, pneumocystis
  • Tachyarrhythmia - in young patients consider cocaine, amphetamines, endocarditis6
  • Jaundice - Hepatitis B, C, or D,anabolic steroids (cholestasis)
  • 'Glandular fever' - may actually be HIV seroconversion illness
  • Pain in a limb or back pain with fever - consider osteomyelitis
  • Severe constipation - unusual in young patient, may be sign of opiate abuse
  • Blindness - may be secondary to fungal or bacterial endophthalmitis with or without endocarditis, or talc or other particulate emboli7
  • Rhinitis - consider opiate withdrawal - other features may be colic/diarrhoea, lacrimation, dilated pupils, insomnia, piloerection, myalgia, low mood (rhinitis may also be a sign of cocaine use).
  • Signs of sensory or motor neuropathy - consider solvent abuse
  • Infarctions - MI, stroke or TIA, spinal - suspect cocaine use8
General management

The general management of substance misuse has been extensively revolutionised with the release of consensus guidelines in 2007.9 These guidelines take on board the NICE suite of guidance on substance misuse as well as other evidence-based studies.10,11,12,13,14 The guidelines cover a wide range of issues and need to be read in detail by health professionals who come into contact with people requiring care for substance misuse. Essential components include:

  • The prevalence of drug misuse in the UK
  • Drug-related morbidity and mortality
  • The impact of drug misuse on families and communities
  • Models of drug treatment
  • Clinical governance principles
  • Non-medical prescribing (i.e. prescribing by health professionals other than doctors or dentists)
  • Confidentiality, information sharing and child protection
  • Patient and carer involvement
  • Assessment, planning care and treatment
  • Drug testing
  • General health assessment
  • Psychosocial components of treatment
  • Pharmacological interventions
  • Assessing and responding to progress and failure to benefit
  • Opioid maintenance prescribing
  • Opioid detoxification
  • Naltrexone for relapse prevention
  • Benzodiazepines
  • Stimulants
  • Preventing drug-related deaths
  • Alcohol misuse
  • Specific clinical situations such as prisoners, pregnant patients, mental health issues and older current and ex-drug users
  • Pain management
  • Hospital admission and discharge


Document references
  1. Chengappa KN, Levine J, Gershon S, et al; Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. Bipolar Disord. 2000 Sep;2(3 Pt 1):191-5. [abstract]
  2. Corkery JM, Schifano F, Ghodse AH, et al; The effects of methadone and its role in fatalities. Hum Psychopharmacol. 2004 Dec;19(8):565-76. [abstract]
  3. Tashkin DP; Airway effects of marijuana, cocaine, and other inhaled illicit agents. Curr Opin Pulm Med. 2001 Mar;7(2):43-61. [abstract]
  4. Prendergast BD; The changing face of infective endocarditis. Heart. 2006 Jul;92(7):879-85. Epub 2005 Oct 10. [abstract]
  5. Tiwari A, Haq AI, Myint F, et al; Acute compartment syndromes. Br J Surg. 2002 Apr;89(4):397-412. [abstract]
  6. White SR; Amphetamine toxicity. Semin Respir Crit Care Med. 2002 Feb;23(1):27-36. [abstract]
  7. Kim RW, Juzych MS, Eliott D; Ocular manifestations of injection drug use. Infect Dis Clin North Am. 2002 Sep;16(3):607-22. [abstract]
  8. Jauma S, Olive M, Ferrer X, et al; Neurologia. 1998 Nov;13(9):417-21. [abstract]
  9. Drug misuse and dependence UK guidelines on clinical management; Department of Health (England), the Scottish Government, Welsh Assembly Government and Northern Ireland Executive 2007
  10. Interventions to reduce substance misuse among vulnerable young people; NICE Guidance 2007
  11. Drug misuse - methadone and buprenorphine; NICE Guidance TA114 2007
  12. Drug misuse - naltrexone; TA115 NICE Guidance 2007
  13. Drug misuse: opioid detoxification:; CG52 NICE Guidance 2007
  14. Psychosocial interventions for drug misuse; NICE Guidance CG51 2007

Internet and further reading Acknowledgements EMIS is grateful to Dr Laurence Knott for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 2073
Document Version: 20
DocRef: bgp644
Last Updated: 30 Oct 2007
Review Date: 29 Oct 2009




















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site














Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page